Medical Doctor Program year 2024 Reported 2020–2024 Source: CMS Open Payments, 2026 publication

Jaime Bastidas

Plastic and Reconstructive Surgery Phillipsburg, NJ Medical Doctor

NPI 1992807705 CMS profile 790044

244 Roseberry St., Suite #5, Phillipsburg, NJ 08865

Open in the dashboard

General payments

$864

10 records reported · program years 2020–2024

Research payments

$0

Paid to them · None reported · program years 2020–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Jaime Bastidas of Phillipsburg, NJ is reported in the CMS Open Payments database as having received $864 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 30th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $39 1
2023 General $278 2
2022 General $25 1
2021 General $203 2
2020 General $318 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jaime Bastidas
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Jaime Bastidas were reported at $0. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Jaime Bastidas Plastic and Reconstructive Surgery median Middle half National median
2019 $0 $335 $121–$1,264 $163
2020 $318 $162 $57–$417 $114
2021 $203 $245 $89–$735 $132
2022 $25 $325 $120–$932 $149
2023 $278 $343 $129–$999 $160
2024 $39 $390 $141–$1,085 $164
2025 $0 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2020–2024
  1. Smith+Nephew, Inc. $327 3 payments
  2. Zimmer Biomet Holdings, Inc. $186 1 payment
  3. Integra LifeSciences Corporation $154 1 payment
  4. Organogenesis Inc. $92 1 payment
  5. Allergan Inc. $50 2 payments
  6. Urgo Medical North America, LLC $39 1 payment
  7. KCI USA, Inc $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2024
  1. Food and Beverage $678 9 payments
  2. Travel and Lodging $186 1 payment
Products named General payments · program years 2020–2024
  1. CMF & Thoracic-None $186 1 payment
  2. Integra Recon-Skin And Wound $154 1 payment
  3. Integra Recon-Skin And Wound $154 1 payment
  4. Integra Recon-Skin And Wound $154 1 payment
  5. INTEGRA DERMAL REGENERATION TEMPLATE $154 1 payment
  6. PRIMATRIX $154 1 payment
  7. COLLAGENASE SANTYL $125 1 payment
  8. GRAFIX $124 1 payment
  9. Puraply $92 1 payment
  10. RENASYS GO $78 1 payment
  11. Other $183 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$1,746,381

Of which drugs: $1,732,975

Medicare patients

11

Average age 81

Services billed

1,759

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 0%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Membrane graft or membrane wrap, per square centimeter Q4205 Office 11 1,616 $1,732,975

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record